Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy

BACKGROUND: Inhaled corticosteroids (ICS) are effective maintenance treatments for childhood asthma; however, many children remain uncontrolled. Vilanterol (VI) is an inhaled long-acting beta-2 agonist which, in combination with the ICS fluticasone furoate, is being explored as a once-daily treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Amanda J., Covar, Ronina A., Goldfrad, Caroline H., Klein, Ryan M., Pedersen, Søren E., Sorkness, Christine A., Tomkins, Susan A., Villarán, César, Grigg, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820901/
https://www.ncbi.nlm.nih.gov/pubmed/27044326
http://dx.doi.org/10.1186/s12931-016-0353-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820901/
https://www.ncbi.nlm.nih.gov/pubmed/27044326
http://dx.doi.org/10.1186/s12931-016-0353-4

Ejemplares similares